C84.Z1
Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code C84.Z1 refers to a specific category of mature T-cell and natural killer (NK) cell lymphomas affecting the lymph nodes in the head, face, and neck region. These are a subset of non-Hodgkin lymphomas characterized by the abnormal growth of T or NK cells, which are types of lymphocytes involved in immune response. The term 'other mature' indicates that these lymphomas originate from fully differentiated lymphocytes, and they may present with diverse clinical features based on their location and subtype.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting lymphocyte development and regulation Exposure to certain chemicals or environmental toxins Previous history of autoimmune diseases Viral infections, such as Epstein-Barr virus (EBV), which have been associated with some lymphomas Immunosuppression due to medications or other medical conditions
Key Symptoms: Persistent swelling or enlargement of the lymph nodes in the head, face, or neck Unexplained weight loss Fever that persists for several days or weeks Night sweats Fatigue or weakness Localized pain or tenderness in the affected areas Difficulty swallowing or breathing if the lymph nodes compress surrounding structures Skin lesions or nodules if the lymphoma extends to the skin
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of medical history assessment, physical examination, imaging studies, and laboratory tests. The key steps include:
Treatment Protocols: Treatment strategies depend on the stage, subtype, and overall health of the patient. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is C84.Z1 a billable ICD-10 code?
Yes, C84.Z1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.Z1?
Clinical documentation must specify the nature of Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck and any associated comorbidities for accurate reporting.
Cite this Clinical Reference